Trial intelligence / Profile preview

Ethanol lock therapy for catheter-related bloodstream infection in TPN patients

NL-OMON33739Not yet recruiting

Sponsor
Amsterdam University Medical Center
Start
Sep 2008
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial in catheter-associated bloodstream infection (CRBSI) comparing Ethanol lock therapy with Placebo lock therapy (2 arms). Primary endpoint: Treatment failure. Planned start Sep 2008; status: not yet recruiting.

02

Drugs

ethanol
03

Conditions

catheter-associated bloodstream infection (CRBSI)

Beyond the preview

Go deeper on NL-OMON33739.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON33739.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call